# David Wofsy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-wofsy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,673 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 55 |
| i10-index | 110 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5054643514 |
| ORCID iD | https://orcid.org/0000-0001-8350-3428 |
| Works | 205 |

## Researcher papers

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus/)
- [The immune cell landscape in kidneys of patients with lupus nephritis](https://scholariq.org/papers/the-immune-cell-landscape-in-kidneys-of-patients-with-lupus-nephritis/)
- [Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-versus-azathioprine-as-maintenance-therapy-for-lupus-nephritis/)
- [Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study](https://scholariq.org/papers/influence-of-race-ethnicity-on-response-to-lupus-nephritis-treatment-the-alms/)
- [Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating trial](https://scholariq.org/papers/reduced-b-lymphocyte-and-immunoglobulin-levels-after-atacicept-treatment-in/)
- [Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis](https://scholariq.org/papers/phase-ii-randomized-trial-of-rituximab-plus-cyclophosphamide-followed-by/)
- [Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus](https://scholariq.org/papers/adoptive-treg-cell-therapy-in-a-patient-with-systemic-lupus-erythematosus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.